1-6 of 6
Lauren C. Harshman
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Open Access
Atish D. Choudhury, Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang, Abhishek Tripathi, Jacqueline M. Kilar, Meredith Flynn, Brianna Maynard, Rebecca Reichel, Amanda F. Pace, Brandon K. Chen, Eliezer M. Van Allen, Kerry Kilbridge, Xiao X. Wei, Bradley A. McGregor, Mark M. Pomerantz, Rupal S. Bhatt, Christopher J. Sweeney, Glenn J. Bubley, Heather A. Jacene, Mary-Ellen Taplin, Franklin W. Huang, Lauren C. Harshman, Lawrence Fong
Journal: Cancer Immunology Research
Cancer Immunol Res (2024) 12 (6): 704–718.
https://doi.org/10.1158/2326-6066.CIR-22-0306
Published: 04 June 2024
View articletitled, Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer
Open the PDF for Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer in another window
Includes: Supplementary data
Journal Articles

Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma

Available to Purchase
Renee Maria Saliby, Talal El Zarif, Ziad Bakouny, Valisha Shah, Wanling Xie, Ronan Flippot, Thomas Denize, M. Harry Kane, Katrine N. Madsen, Miriam Ficial, Laure Hirsch, Xiao X. Wei, John A. Steinharter, Lauren C. Harshman, Ulka N. Vaishampayan, Mariano Severgnini, David F. McDermott, Gwo-Shu Mary Lee, Wenxin Xu, Eliezer M. Van Allen, Bradley A. McGregor, Sabina Signoretti, Toni K. Choueiri, Rana R. McKay, David A. Braun
Journal: Cancer Immunology Research
Cancer Immunol Res (2023) 11 (8): 1114–1124.
https://doi.org/10.1158/2326-6066.CIR-22-0996
Published: 03 August 2023
View articletitled, Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma
Open the PDF for Circulating and Intratumoral Immune Determinants of Response to Atezolizumab plus Bevacizumab in Patients with Variant Histology or Sarcomatoid Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma

Available to Purchase
Rana R. McKay, Dominick Bossé, Wanling Xie, Stephanie A.M. Wankowicz, Abdallah Flaifel, Raphael Brandao, Aly-Khan A. Lalani, Dylan J. Martini, Xiao X. Wei, David A. Braun, Eliezer Van Allen, Daniel Castellano, Guillermo De Velasco, J. Connor Wells, Daniel Y. Heng, Andre P. Fay, Fabio A. Schutz, JoAnn Hsu, Sumanta K. Pal, Jae Lyun Lee, James J. Hsieh, Lauren C. Harshman, Sabina Signoretti, Robert J. Motzer, Darren Feldman, Toni K. Choueiri
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (7): 758–765.
https://doi.org/10.1158/2326-6066.CIR-17-0475
Published: 01 July 2018
View articletitled, The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma
Open the PDF for The Clinical Activity of PD-1/PD-L1 Inhibitors in Metastatic Non–Clear Cell Renal Cell Carcinoma in another window
Includes: Supplementary data
Journal Articles

Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events

Available to Purchase
Dylan J. Martini, Lana Hamieh, Rana R. McKay, Lauren C. Harshman, Raphael Brandao, Craig K. Norton, John A. Steinharter, Katherine M. Krajewski, Xin Gao, Fabio A. Schutz, Bradley McGregor, Dominick Bossé, Aly-Khan A. Lalani, Guillermo De Velasco, M. Dror Michaelson, David F. McDermott, Toni K. Choueiri
Journal: Cancer Immunology Research
Cancer Immunol Res (2018) 6 (4): 402–408.
https://doi.org/10.1158/2326-6066.CIR-17-0220
Published: 01 April 2018
View articletitled, Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events
Open the PDF for Durable Clinical Benefit in Metastatic Renal Cell Carcinoma Patients Who Discontinue PD-1/PD-L1 Therapy for Immune-Related Adverse Events in another window
Journal Articles

PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond

Available to Purchase
Lauren C. Harshman, Charles G. Drake, Toni K. Choueiri
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (12): 1132–1141.
https://doi.org/10.1158/2326-6066.CIR-14-0193
Published: 04 December 2014
View articletitled, PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond
Open the PDF for PD-1 Blockade in Renal Cell Carcinoma: To Equilibrium and Beyond in another window
Journal Articles

Cancer Immunotherapy Highlights from the 2014 ASCO Meeting

Available to Purchase
Lauren C. Harshman, Charles G. Drake, Jennifer A. Wargo, Padmanee Sharma, Nina Bhardwaj
Journal: Cancer Immunology Research
Cancer Immunol Res (2014) 2 (8): 714–719.
https://doi.org/10.1158/2326-6066.CIR-14-0119
Published: 03 August 2014
View articletitled, Cancer Immunotherapy Highlights from the 2014 ASCO Meeting
Open the PDF for Cancer Immunotherapy Highlights from the 2014 ASCO Meeting in another window